查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1912825

主动和被动式上下肢训练系统市场（按设备、系统、治疗方法、患者年龄层、组件、应用和最终用户划分）—2026年至2032年全球预测

Upper & Lower Limb Active & Passive Training System Market by Device Type, System Type, Therapy Type, Patient Age Group, Component, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，主动和被动上下肢训练系统市场价值将达到 17.4 亿美元，到 2026 年将成长到 18.4 亿美元，到 2032 年将达到 26 亿美元，复合年增长率为 5.86%。

关键市场统计数据
基准年 2025 17.4亿美元
预计年份：2026年 18.4亿美元
预测年份 2032 26亿美元
复合年增长率 (%) 5.86%

为主动和被动式上下肢训练系统提供策略背景，深入分析临床路径、采购决策和创新投资重点。

本执行摘要为临床医生、采购经理、产品开发人员和投资者提供了一份简洁明了、切实可行的上肢和下肢主动及被动训练系统现状概述。透过分析设备和系统分类以及临床和商业性因素，帮助相关人员快速确立策略方向并确定近期投资重点。报告整合了设备层面的差异化（从非机器人等速设备和振动系统到机器人末端执行器和外骨骼解决方案），以及主动和被动模式下的系统性能，同时重点阐述了各细分领域中诊所、居家照护机构和医院面临的实际运作情况。

技术创新、以服务为中心的模式和临床证据的融合如何重新定义肢体復健设备的设计、实施和商业性价值

技术、临床和交付模式的整合变革正在重塑市场格局，从根本上改变了肢体训练系统的设计、采购和部署方式。微型致动器和高精度感测器的进步使得以往仅限于医院环境的紧凑型硬体得以应用，从而加速了对可在诊所和居家照护环境中可靠使用的设备的需求。同时，软体驱动的分析和控制系统正从辅助功能发展成为核心差异化因素，实现封闭回路型治疗和远端监测，从而提高护理的连续性并展现可衡量的长期疗效。

检验2025 年关税变化带来的变化，并考虑了极端训练系统供应链的重组、采购经济学和国内製造业奖励。

2025年美国关税调整为肢体復健系统供应链带来了新的挑战与机会。其累积影响在硬体密集细分领域最为显着，这些领域普遍依赖进口致动器、精密感测器和专用机械组件。为此，采购团队和製造商正在重新调整筹资策略，一些供应商采取近岸外包和双重采购方式来降低风险，而另一些供应商则重新协商组件规格，以在不影响临床性能的前提下减轻关税负担。

一种将设备架构、治疗方式、终端用户实际情况和组件生态系统连结起来的分层分割框架，用于确定研发和商业化路径的优先顺序。

更精细的细分方法揭示了产品开发和商业性化重点能够带来最大临床和经济回报的领域。设备类型划分将非机器人系统（以等速设备和振动平台为代表）与机器人解决方案（归类于末端执行器和外骨骼架构）区分开来。每类设备都有不同的临床工作流程、资本密集度和服务需求，并且通常在多学科復健方案中发挥互补作用。系统类型划分透过区分主动和被动模式，进一步明确了临床应用。主动系统强调患者主导的运动和运动功能再训练，而被动系统则针对辅助关节活动度练习和早期术后復健通讯协定进行了优化。

美洲、欧洲、中东和非洲以及亚太地区的区域采用趋势和监管差异将决定每个市场的商业化和服务策略。

区域趋势对肢体復健系统的采用模式、监管重点和商业模式有显着影响，因此需要製定针对特定区域的市场进入和规模化策略。在美洲，整合式医疗服务体系、高度集中的专业復健中心以及人们对居家照护解决方案日益增长的兴趣正在塑造市场需求。该地区的支付模式和报销途径强调已证实的临床疗效和成本效益，因此，可靠的临床证据和长期使用指标的重要性日益凸显。

透过策略伙伴关係实现竞争差异化，这些合​​作伙伴关係结合了整合技术堆迭、服务网络、临床证据和商业规模。

在肢体训练系统领域，竞争优势取决于差异化的技术平台、临床证据以及提供高利用率和良好患者疗效的服务的能力。业界领导企业将严谨的临床检验与完善的服务网路和成熟的软体平台相结合，从而支援数据分析和远端监测。同时，一群新兴的专业创新者正专注于特定的临床适应症和设备创新，例如紧凑型家用外骨骼和模组化末端执行器单元，以挑战现有企业在价格、易用性和远端復健路径整合方面的不足。

为製造商和供应商提供切实可行的策略性倡议，以扩展模组化平台、拓宽服务范围并展现临床价值，同时降低关税和价值链风险。

产业领导者应优先考虑一系列切实可行的倡议，使产品开发与临床工作流程和支付方预期保持一致，同时在不断变化的关税和供应链环境中保障利润。首先，关键在于投资模组化架构，使底层硬体平台能够同时支援主动和被动治疗模式，并可逐步升级致动器、感测器和软体功能。这种方法将加快新治疗模组的上市速度，并允许为每个最终用户（无论是专科诊所、医院復健中心还是居家照护客户）提供客製化配置。

一项透明的混合方法研究结合了专家访谈、技术设备审查、供应链分析和临床文献检验，确保了研究结果的可靠性。

本执行摘要的研究结合了定性专家对话、严谨的二手分析和三角验证，以确保提供客观、可操作的见解。主要研究包括对临床医生、采购人员、设备工程师和医疗系统管理人员进行结构化访谈，以了解实际工作流程、未满足的临床需求和采购标准。这些访谈辅以对涵盖致动器、感测器和控制系统的设备架构的技术审查，以及与神经病学、整形外科和运动医学应用相关的临床试验终点和復健通讯协定的分析。

整合临床、技术和商业性需求，以确定可在多种医疗环境中有效扩展的产品和服务策略。

总之，上下肢主动和被动训练系统的市场环境正处于一个转折点，技术成熟度、不断演进的医疗服务模式和不断变化的商业性动态在此交汇融合。能够设计模组化、可升级平台并将其与强大的服务和分析解决方案相结合的製造商，将更有能力满足医院、诊所和居家医疗机构的多样化需求。关税趋势和供应链重组要求製造商谨慎选择采购和生产环节，而临床证据仍然是医疗保险报销和广泛应用的关键驱动因素，尤其是在中风和脊髓復健等神经系统疾病领域。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依设备类型分類的上肢及下肢主动及被动训练系统市场

  • 非机器人
    • 等速运动装置
    • 振动
  • 机器人
    • 末端执行器
    • 外骨骼

9. 上肢及下肢主动及被动训练系统市场（依系统类型划分）

  • 积极的
  • 被动的

第十章 依治疗类型分類的上肢及下肢主动及被动训练系统市场

  • 运动功能
    • 精细动作功能
    • 大运动功能
  • 活动范围
    • 主动辅助活动范围训练
    • 被动关节活动度练习
  • 肌力训练
    • 下肢
    • 上肢

11. 依患者年龄层分類的上肢及下肢主动及被动训练系统市场

  • 成人版
    • 18-45岁
    • 46-65岁
  • 老年人
    • 65-80
    • 80岁或以上
  • 儿童
    • 青春期
    • 新生

12. 上下肢主动和被动训练系统市场（按组件划分）

  • 硬体
    • 致动器
    • 感应器
  • 服务
    • 安装
    • 维护
  • 软体
    • 分析
    • 控制系统

13. 依应用分類的上肢及下肢主动及被动训练系统市场

  • 神经系统
    • 脊髓
    • 中风
  • 整形外科
    • 骨折復健
    • 术后
  • 运动医学
    • 伤害预防
    • 绩效改进

14. 依最终使用者分類的上肢及下肢主动及被动训练系统市场

  • 诊所
    • 一般的
    • 专业
  • 居家照护
  • 医院
    • 门诊部
    • 復健中心

15. 各区域上下肢主动及被动训练系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

16. 上下肢主动与被动训练系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

17. 各国上肢及下肢主动及被动训练系统市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国上下肢主动与被动训练系统市场

19. 中国主动与被动式上下肢训练系统市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AlterG, Inc.
  • Bionik Laboratories Corp.
  • BTL Industries
  • Cyberdyne, Inc.
  • DJO Global
  • Ekso Bionics Holdings, Inc.
  • Fourier Intelligence
  • Hocoma AG
  • Kinova Inc.
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • Parker-Hannifin Corporation
  • Performance Health, Inc.
  • ReWalk Robotics Ltd.
  • Tyromotion GmbH
Product Code: MRR-AE420CB13AC0

The Upper & Lower Limb Active & Passive Training System Market was valued at USD 1.74 billion in 2025 and is projected to grow to USD 1.84 billion in 2026, with a CAGR of 5.86%, reaching USD 2.60 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.74 billion
Estimated Year [2026] USD 1.84 billion
Forecast Year [2032] USD 2.60 billion
CAGR (%) 5.86%

Framing the strategic context for upper and lower limb active and passive training systems to inform clinical pathways, procurement decisions, and innovation investment priorities

This executive summary provides a concise, actionable synthesis of the contemporary landscape for upper and lower limb active and passive training systems, designed for clinicians, procurement leaders, product innovators, and investors. The analysis frames device and system typologies alongside clinical and commercial drivers so stakeholders can rapidly orient strategy and prioritize near-term investments. The narrative integrates device-level distinctions-from non-robotic isokinetic machines and vibration systems to robotic end-effector and exoskeleton solutions-with system behavior across active and passive modalities, while maintaining focus on the operational realities faced by clinics, home care providers, and hospitals in their various subsegments.

The intent is to articulate the strategic inflection points shaping capital allocation, product development, and service models. To do so, the summary synthesizes technological advances in actuators, sensors, analytics and control systems with evolving therapy paradigms that span motor function, range of motion and strength training. In doing so, it remains attentive to patient segmentation by age group and clinical application, ensuring that the insights produced are clinically meaningful as well as commercially actionable. Transitional commentary connects macro trends to component-level implications so that readers can translate high-level intelligence into tactical plans for R&D prioritization, channel strategy, and clinical validation requirements.

How converging technological advances, service-centric models, and clinical evidence are redefining device design, deployment, and commercial value in limb rehabilitation

The market is being reshaped by convergent technological, clinical, and delivery-model shifts that are fundamentally altering how limb training systems are designed, purchased, and deployed. Advances in miniaturized actuators and high-fidelity sensors are enabling more compact hardware footprints that were previously confined to hospital environments, which in turn is accelerating demand for devices capable of reliable use in clinics and home care settings. Simultaneously, software-driven analytics and control systems are progressing from adjunctive features to core differentiators, enabling closed-loop therapies and remote monitoring that improve adherence and demonstrate measurable outcomes over time.

There is a clear movement from monolithic, single-use platforms toward modular solutions that can be configured across active and passive modalities to meet heterogeneous clinical protocols. This is accompanied by greater emphasis on human-centered design for exoskeletons and end-effector robots, reducing setup time and lowering training requirements for clinicians. Tele-rehabilitation and hybrid care pathways are gaining traction, and the integration of AI-assisted decision support into therapy planning is shifting the value proposition from hardware-alone to hardware-plus-software-and-services. As a result, service components such as installation and maintenance, along with advanced analytics, are accruing a larger role in lifetime product economics.

Clinically, the expanding evidence base for neurological applications-particularly stroke and spinal cord rehabilitation-is elevating the role of robotic assistance alongside established orthopedic and sports medicine indications. Equally important, demographic pressures and rising rates of chronic conditions are increasing volume and complexity across adult, geriatric, and pediatric cohorts, compelling providers to adopt scalable and interoperable solutions. Collectively, these transformative shifts require manufacturers and health systems to re-evaluate pricing strategies, training curricula, and reimbursement engagement to capture the full value enabled by integrated technology stacks.

Examining the 2025 tariff-induced shifts that reconfigured supply chains, procurement economics, and domestic manufacturing incentives for limb training systems

United States tariff changes implemented in 2025 have introduced a new set of constraints and opportunities across the supply chain for limb rehabilitation systems. The cumulative impact has been most acute for hardware-intensive subsegments where imported actuators, precision sensors, and specialized mechanical assemblies are common inputs. In response, procurement teams and manufacturers are recalibrating sourcing strategies, with some suppliers pursuing nearshoring or dual-sourcing to mitigate exposure and others renegotiating component specifications to reduce tariff burdens without compromising clinical performance.

The tariff environment has also influenced total cost of ownership assessments for end users. Hospitals and large clinics are increasingly evaluating not only acquisition cost but also lifecycle expenses such as maintenance, software subscriptions, and spare-part availability. For some device categories, price pass-through to purchasers has blurred the distinction between capital procurement and subscription-based models, accelerating interest in service agreements that bundle installation and maintenance and thereby provide predictable budgeting.

On the other hand, tariff-driven cost pressure has created competitive openings for domestic manufacturers and contract manufacturers capable of delivering compliant components at competitive cost points. This is most relevant for complex robotic solutions such as exoskeletons and end-effector devices, where a local supply base reduces risk and shortens lead times for installation and maintenance. In parallel, software and analytics vendors-less affected by physical tariff barriers-have positioned cloud-native platforms and remote support services as differentiators, helping customers offset hardware premium through improved utilization and outcome tracking. Overall, the tariff adjustments are accelerating structural shifts in procurement strategy, manufacturing footprint planning, and commercial contracting across the ecosystem.

A layered segmentation framework that connects device architectures, therapy modalities, end-user realities, and component ecosystems to prioritize R&D and commercialization pathways

A nuanced approach to segmentation illuminates where product development and commercial focus will deliver the greatest clinical and financial return. Device type distinctions separate non-robotic systems, represented by isokinetic machines and vibration platforms, from robotic solutions that fall into end-effector and exoskeleton architectures. Each device lineage carries different clinical workflows, capital intensity, and service needs, and they often serve complementary roles within multidisciplinary rehabilitation programs. System type segmentation, distinguishing active and passive modalities, further clarifies clinical application: active systems emphasize patient-initiated movement and motor relearning while passive systems are optimized for assisted range of motion and early post-operative protocols.

End-user segmentation reveals distinct adoption dynamics across clinics, which include general and specialty practices, home care environments, and hospitals that operate both outpatient departments and rehabilitation centers. Home care adoption favors compact hardware, remote monitoring software, and simplified maintenance pathways, whereas hospitals prioritize throughput, interoperability, and robust service agreements. Application-based segmentation highlights neurological use cases such as spinal cord and stroke rehabilitation, orthopedic pathways encompassing fracture rehabilitation and post-operative recovery, and sports medicine goals focused on injury prevention and performance enhancement. Therapy-type distinctions-spanning motor function with fine and gross motor modules, range of motion with active assisted and passive ROM strategies, and strength training differentiated into lower limb and upper limb focus-drive device control paradigms and outcome measures.

Patient age group segmentation underscores the need for adaptable interfaces and safety features across adult cohorts (18-45 and 46-65), geriatric populations (65-80 and 80+), and pediatric users (adolescents and neonatal). Component-level segmentation draws attention to hardware elements such as actuators and sensors, service offerings including installation and maintenance, and software capabilities in analytics and control systems that increasingly determine long-term value. When synthesized, these segmentation layers provide a framework to prioritize product roadmaps, clinical validation pathways, and commercialization strategies that match therapy objectives with end-user constraints and demographic realities.

Regional adoption dynamics and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that dictate tailored commercialization and service strategies

Regional dynamics materially influence adoption patterns, regulatory priorities, and commercial models for limb training systems, requiring tailored strategies for market entry and scale. In the Americas, demand is shaped by integrated healthcare delivery systems, a high concentration of specialized rehabilitation centers, and growing interest in home-based care solutions. Payor models and reimbursement pathways in this region emphasize demonstrated clinical outcomes and cost-effectiveness, which elevates the importance of robust clinical evidence and long-term utilization metrics.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization within parts of Europe facilitates cross-border product registrations, while other markets emphasize localized procurement and clinician training. Reimbursement is variable, and adoption often depends on regional centers of excellence that can validate new technologies and generate referral pathways. In several markets, public health systems and budget cycles influence purchasing, prompting vendors to develop flexible financing models and local service capabilities.

Asia-Pacific is characterized by rapid adoption in urban centers, a growing private healthcare sector, and significant investments in digital health infrastructure. Regional manufacturing capabilities and supply-chain clusters in parts of Asia-Pacific can reduce time-to-market, but regulatory diversity and varying standards for clinical evidence require nuanced market entry approaches. Across all regions, adoption is strongly correlated with the maturity of home care ecosystems, the availability of trained therapists, and reimbursement frameworks that recognize the value of integrated software and service offerings. Understanding these regional subtleties enables manufacturers to calibrate product configurations, service commitments, and commercial partnerships for maximum impact.

Competitive differentiation driven by integrated technology stacks, service networks, and strategic partnerships that align clinical evidence with commercial scale

Competitive positioning in the limb training systems space is driven by differentiated technology stacks, clinical evidence, and the ability to deliver services that ensure high utilization and patient outcomes. Established leaders often combine rigorous clinical validation with comprehensive service networks and mature software platforms that support analytics and remote monitoring. At the same time, a new cohort of specialized innovators focuses on narrowing clinical indications or device form factors-such as compact home-use exoskeletons or modular end-effector units-that challenge incumbents on price, ease of use, and integration into tele-rehabilitation pathways.

Partnerships between hardware manufacturers and software analytics providers are increasingly common, enabling vendors to present integrated value propositions that encompass installation, maintenance, and outcome measurement. Additionally, some companies are vertically integrating supply chains to mitigate tariff exposure and reduce lead times for critical components like actuators and sensors. Investors and corporate development teams are tracking M&A activity that consolidates hardware, software, and service capabilities to accelerate scale and broaden the addressable market. For purchasers, vendor selection now weighs not only device performance but also the vendor's capacity to provide training, maintenance, and data-driven evidence of clinical and economic benefit over the product lifecycle.

Actionable strategic initiatives for manufacturers and providers to scale modular platforms, expand services, and mitigate tariff and supply-chain risks while demonstrating clinical value

Industry leaders should prioritize a set of actionable initiatives that align product development with clinical workflows and payor expectations, while also protecting margins in a changing tariff and supply-chain environment. First, invest in modular architectures that permit a base hardware platform to support both active and passive modalities and to accept incremental upgrades for actuators, sensors, and software capabilities. This approach reduces time-to-market for new therapy modules and allows for tailored configurations by end user, whether that is a specialty clinic, a hospital rehabilitation center, or a home care customer.

Second, expand service offerings that bundle installation, preventative maintenance, and remote analytics, converting one-time sales into recurring revenue streams and improving device uptime. Third, pursue nearshoring and dual-sourcing strategies for critical hardware components to mitigate tariff exposure while maintaining competitive lead times; simultaneously, explore partnerships with regional manufacturing hubs to lower logistics costs and improve responsiveness to local demand. Fourth, strengthen clinical evidence generation through targeted trials in neurological and orthopedic applications, ensuring publications emphasize functional outcomes that payors and procurement committees recognize. Lastly, tailor commercial models by region: prioritize outcome-based contracting and financing solutions in markets where reimbursement is constrained, and emphasize performance and interoperability in markets with advanced home care adoption. Collectively, these measures will help organizations capture share while addressing the operational realities of clinicians and procurement teams.

A transparent mixed-methods research approach combining expert interviews, technical device reviews, supply-chain mapping, and clinical literature triangulation to ensure robust insights

The research underpinning this executive summary combines qualitative expert engagement with rigorous secondary analysis and triangulation to ensure objective, actionable findings. Primary research involved structured interviews with clinicians, procurement leaders, device engineers, and health system administrators to capture real-world workflows, unmet clinical needs, and purchasing criteria. These interviews were complemented by technical reviews of device architectures-spanning actuators, sensors, and control systems-and by analysis of clinical trial endpoints and rehabilitation protocols relevant to neurological, orthopedic, and sports medicine applications.

Secondary research comprised a systematic review of peer-reviewed clinical literature, regulatory filings, and product technical specifications to validate performance claims and identify trends in user experience and safety features. Supply-chain mapping assessed component sourcing, tariff exposure, and manufacturing footprints to identify practical levers for cost and lead-time optimization. Findings were triangulated across data sources, and sensitivity checks were performed to ensure robustness of thematic conclusions. Finally, internal quality-control processes verified consistency and clarity of definitions used across segmentation dimensions such as device type, system type, end user, therapy type, patient age group, and component classification, ensuring that insights are reproducible and relevant for decision-making.

Synthesis of clinical, technological, and commercial imperatives that determine which product and service strategies will scale effectively across diverse care settings

In conclusion, the landscape for upper and lower limb active and passive training systems is at an inflection point where technological maturity, evolving care delivery models, and shifting commercial dynamics converge. Manufacturers that design modular, upgradeable platforms and pair them with robust service and analytics offerings will be best positioned to meet the divergent needs of hospitals, clinics, and home care settings. tariff dynamics and supply-chain reconfiguration require deliberate sourcing and manufacturing choices, while clinical evidence remains the critical enabler for reimbursement and broad adoption, particularly in neurological indications such as stroke and spinal cord rehabilitation.

Decision-makers should focus on aligning product roadmaps with therapy-specific requirements-whether fine motor recovery, passive range-of-motion protocols, or strength training for upper and lower limbs-while ensuring that interfaces and safety features address the needs of adult, geriatric, and pediatric populations. By integrating thoughtful regional strategies that reflect the unique market and regulatory conditions across the Americas, Europe Middle East & Africa, and Asia-Pacific, organizations can accelerate adoption and create differentiated value. Ultimately, success will hinge on the ability to translate device innovation into verifiable clinical outcomes and predictable operational economics for providers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Upper & Lower Limb Active & Passive Training System Market, by Device Type

  • 8.1. Non Robotic
    • 8.1.1. Isokinetic Machines
    • 8.1.2. Vibration
  • 8.2. Robotic
    • 8.2.1. End Effector
    • 8.2.2. Exoskeleton

9. Upper & Lower Limb Active & Passive Training System Market, by System Type

  • 9.1. Active
  • 9.2. Passive

10. Upper & Lower Limb Active & Passive Training System Market, by Therapy Type

  • 10.1. Motor Function
    • 10.1.1. Fine Motor
    • 10.1.2. Gross Motor
  • 10.2. Range Of Motion
    • 10.2.1. Active Assisted ROM
    • 10.2.2. Passive ROM
  • 10.3. Strength Training
    • 10.3.1. Lower Limb
    • 10.3.2. Upper Limb

11. Upper & Lower Limb Active & Passive Training System Market, by Patient Age Group

  • 11.1. Adult
    • 11.1.1. 18-45
    • 11.1.2. 46-65
  • 11.2. Geriatric
    • 11.2.1. 65-80
    • 11.2.2. 80+
  • 11.3. Pediatric
    • 11.3.1. Adolescents
    • 11.3.2. Neonatal

12. Upper & Lower Limb Active & Passive Training System Market, by Component

  • 12.1. Hardware
    • 12.1.1. Actuators
    • 12.1.2. Sensors
  • 12.2. Service
    • 12.2.1. Installation
    • 12.2.2. Maintenance
  • 12.3. Software
    • 12.3.1. Analytics
    • 12.3.2. Control Systems

13. Upper & Lower Limb Active & Passive Training System Market, by Application

  • 13.1. Neurological
    • 13.1.1. Spinal Cord
    • 13.1.2. Stroke
  • 13.2. Orthopedic
    • 13.2.1. Fracture Rehab
    • 13.2.2. Post Op
  • 13.3. Sports Medicine
    • 13.3.1. Injury Prevention
    • 13.3.2. Performance Enhancement

14. Upper & Lower Limb Active & Passive Training System Market, by End User

  • 14.1. Clinics
    • 14.1.1. General
    • 14.1.2. Specialty
  • 14.2. Home Care
  • 14.3. Hospitals
    • 14.3.1. Outpatient Department
    • 14.3.2. Rehabilitation Center

15. Upper & Lower Limb Active & Passive Training System Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Upper & Lower Limb Active & Passive Training System Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Upper & Lower Limb Active & Passive Training System Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Upper & Lower Limb Active & Passive Training System Market

19. China Upper & Lower Limb Active & Passive Training System Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AlterG, Inc.
  • 20.6. Bionik Laboratories Corp.
  • 20.7. BTL Industries
  • 20.8. Cyberdyne, Inc.
  • 20.9. DJO Global
  • 20.10. Ekso Bionics Holdings, Inc.
  • 20.11. Fourier Intelligence
  • 20.12. Hocoma AG
  • 20.13. Kinova Inc.
  • 20.14. Myomo, Inc.
  • 20.15. Ottobock SE & Co. KGaA
  • 20.16. Parker-Hannifin Corporation
  • 20.17. Performance Health, Inc.
  • 20.18. ReWalk Robotics Ltd.
  • 20.19. Tyromotion GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ISOKINETIC MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ISOKINETIC MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ISOKINETIC MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY VIBRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY VIBRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY VIBRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END EFFECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END EFFECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END EFFECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY EXOSKELETON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY EXOSKELETON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY EXOSKELETON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FINE MOTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FINE MOTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FINE MOTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GROSS MOTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GROSS MOTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GROSS MOTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE ASSISTED ROM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE ASSISTED ROM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTIVE ASSISTED ROM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE ROM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE ROM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PASSIVE ROM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY UPPER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY UPPER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 18-45, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 18-45, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 18-45, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 46-65, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 46-65, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 46-65, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 65-80, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 65-80, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 65-80, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 80+, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 80+, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY 80+, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADOLESCENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADOLESCENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEONATAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTUATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTUATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ACTUATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INSTALLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INSTALLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CONTROL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CONTROL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CONTROL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPINAL CORD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPINAL CORD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPINAL CORD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STROKE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STROKE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FRACTURE REHAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FRACTURE REHAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY FRACTURE REHAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY POST OP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY POST OP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY POST OP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INJURY PREVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INJURY PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY INJURY PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PERFORMANCE ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PERFORMANCE ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PERFORMANCE ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY OUTPATIENT DEPARTMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY OUTPATIENT DEPARTMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY OUTPATIENT DEPARTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY REHABILITATION CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY REHABILITATION CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY REHABILITATION CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NON ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ROBOTIC, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY MOTOR FUNCTION, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY RANGE OF MOTION, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY STRENGTH TRAINING, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 244. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 246. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SPORTS MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 248. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 250. LATIN AMERICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA UPPER & LOWER LIMB ACTIVE & PASSIVE TRAINING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA UP